We previously reported a drug-resistant focal epilepsy patient who had both a responsive neurostimulator (RNS) and continuous glucose monitoring (CGM) device for type I diabetes mellitus [1] . We found lower relative glucose and earlier morning onsets for right temporal seizures when compared to left temporal seizures. The RNS detects provider-defined ictal patterns on electrocorticography (ECoG) and stimulates the brain in response to those patterns. These are automatically recorded as detections and are summated hourly [2] . RNS monitoring shows various ultradian, infradian or multidien rhythms apparent in both detection and seizure events. The ictal patterns on ECoG varies by location of seizure onset [1] [2] [3] .
In RNS patients, detections may be triggered by abundant interictal abnormalities [2] . Interictal abnormalities may not always translate into ictal events [4] . It's an important concept though to separate the interictal-ictal spectrum, as the reasons for the transition may suggest clues to seizure prediction and subsequent control. In our prior report we showed circadian glucose variances may predispose to focal seizures and confer a time-based risk. In this case report, tissue glucose and RNS detections demonstrate a circadian relationship between glucose levels, sleep, and RNS events. The relationship between the data may help individualize epilepsy and diabetes management. Understanding when glucose, sleep and RNS event detection and seizures show similar correlations and polar relationships in broader populations with focal (or generalized) epilepsy might give new perspectives on seizure prediction and management. This may be particularly relevant for patients with anti-epilepsy therapies that rely on carbohydrate regulation such as the ketogenic diet. It's likely that understanding the influence of glucose on ictal and interictal epileptiform activity remains contingent on analyzing long durations of ambulatory ECoG recorded by continuous surveillance devices. 
